Publication: Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
dc.contributor.author | Gallego-Durán, Rocío | |
dc.contributor.author | Cerro-Salido, Pablo | |
dc.contributor.author | Gomez-Gonzalez, Emilio | |
dc.contributor.author | Pareja, María Jesús | |
dc.contributor.author | Ampuero, Javier | |
dc.contributor.author | Rico, María Carmen | |
dc.contributor.author | Aznar, Rafael | |
dc.contributor.author | Vilar-Gomez, Eduardo | |
dc.contributor.author | Bugianesi, Elisabetta | |
dc.contributor.author | Crespo, Javier | |
dc.contributor.author | González-Sánchez, Francisco José | |
dc.contributor.author | Aparcero, Reyes | |
dc.contributor.author | Moreno, Inmaculada | |
dc.contributor.author | Soto, Susana | |
dc.contributor.author | Arias-Loste, María Teresa | |
dc.contributor.author | Abad, Javier | |
dc.contributor.author | Ranchal, Isidora | |
dc.contributor.author | Andrade, Raúl Jesús | |
dc.contributor.author | Calleja, Jose Luis | |
dc.contributor.author | Pastrana, Miguel | |
dc.contributor.author | Lo Iacono, Oreste | |
dc.contributor.author | Romero-Gómez, Manuel | |
dc.contributor.authoraffiliation | [Gallego-Durán,R; Ampuero,J; Rico,MC; Vilar-Gomez,E; Ranchal,I; Romero-Gómez,M] UCM Digestive Diseases and CIBEREHD, Virgen Macarena-Virgen del Rocío University Hospitals, University of Sevilla. Instituto de Biomedicina de Sevilla (IBiS), University of Sevilla, Sevilla, Spain. [Cerro-Salido,P; Gomez-Gonzalez,E] Group of Interdisciplinary Physics, Engineering School, University of Sevilla, Sevilla, Spain. [Pareja,MJ] Pathology Unit, Valme University Hospital, University of Sevilla, Sevilla, Spain. [Aznar,R] Radiology Unit, Valme University Hospital, University of Sevilla, Sevilla, Spain. [Bugianesi,E] Medical Sciences, University of Torino, Torino, Italy. [Crespo,J; Arias-Loste,MT] IDIVAL, Marqués de Valdecilla University Hospital, Gastroenterology and Hepatology Service, Santander, Spain. [González-Sánchez,FJ] Radiology Unit, Marqués de Valdecilla University Hospital, Santander, Spain. [Aparcero,R] UCM Digestive Diseases, Valme University Hospital, Sevilla, Spain. [Moreno,I; Andrade,RJ] UCM Digestive Diseases and CIBEREHD, Virgen de la Victoria University Hospital, Málaga, Spain. [Soto,S; Lo Iacono,O] UCM Digestive Diseases, Tajo University Hospital, Madrid, Spain. [Calleja,JL] UCM Digestive Diseases, Puerta de Hierro University Hospital, Madrid, Spain. [Pastrana,M] Radiology Unit, Puerta de Hierro University Hospital, Madrid, Spain. | es |
dc.contributor.funder | The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement #HEALTH-F2-2009-241762 for the project Fatty Liver Inhibition of Progression (FLIP) and from Consejería de Salud de la Junta de Andalucía under grant agreement #PI-0488-2012/2012. Imaging biomarkers (NASHMRI and FibroMRI) are protected by a European patent #EP15382118. | |
dc.date.accessioned | 2016-09-22T07:44:09Z | |
dc.date.available | 2016-09-22T07:44:09Z | |
dc.date.issued | 2016-08-12 | |
dc.description | Journal Article; | es |
dc.description.abstract | There is a need, in NAFLD management, to develop non-invasive methods to detect steatohepatitis (NASH) and to predict advanced fibrosis stages. We evaluated a tool based on optical analysis of liver magnetic resonance images (MRI) as biomarkers for NASH and fibrosis detection by investigating patients with biopsy-proven NAFLD who underwent magnetic resonance (MR) protocols using 1.5T General Electric (GE) or Philips devices. Two imaging biomarkers (NASHMRI and FibroMRI) were developed, standardised and validated using area under the receiver operating characteristic curve (AUROC) analysis. The results indicated NASHMRI diagnostic accuracy for steatohepatitis detection was 0.83 (95% CI: 0.73-0.93) and FibroMRI diagnostic accuracy for significant fibrosis determination was 0.85 (95% CI: 0.77-0.94). These findings were independent of the MR system used. We conclude that optical analysis of MRI has high potential to define non-invasive imaging biomarkers for the detection of steatohepatitis (NASHMRI) and the prediction of significant fibrosis (FibroMRI) in NAFLD patients. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Gallego-Durán R, Cerro-Salido P, Gomez-Gonzalez E, Pareja MJ, Ampuero J, Rico MC, et al. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Sci Rep. 2016; 6:31421 | es |
dc.identifier.doi | 10.1038/srep31421 | |
dc.identifier.essn | 2045-2322 | |
dc.identifier.pmc | PMC4981860 | |
dc.identifier.pmid | 27514671 | |
dc.identifier.uri | http://hdl.handle.net/10668/2426 | |
dc.journal.title | Scientific Reports | |
dc.language.iso | en | |
dc.publisher | Nature Publishing Group | es |
dc.relation.publisherversion | http://www.nature.com/articles/srep31421#abstract | es |
dc.rights.accessRights | open access | |
dc.subject | Área bajo la curva | es |
dc.subject | Biopsia | es |
dc.subject | Espectroscopía de resonancia magnética | es |
dc.subject | Curva ROC | es |
dc.subject | Biomarcadores | es |
dc.subject | Esteatosis hepática no alcohólica | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Area Under Curve | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cytodiagnosis::Biopsy | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Chemistry Techniques, Analytical::Spectrum Analysis::Magnetic Resonance Spectroscopy | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Sensitivity and Specificity::ROC Curve | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Biological Factors::Biomarkers | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Fatty Liver::Non-alcoholic Fatty Liver Disease | es |
dc.title | Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- GallegoDuranR_Imagingbiomarkers.pdf
- Size:
- 393.13 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado